Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Third Prospective, Observational, International, Multicenter Study on Mechanical Ventilation
OBSERVATIONAL
Inicio: 1 de abr de 2010
ID: NCT01093482
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents
INTERVENTIONAL
Inicio: 20 de sept de 2012
ID: NCT01686633
Completado
Fase 2
ClinicalTrials.gov
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART STUDY TO EVALUATE EDP-938 REGIMENS IN SUBJECTS AGED 28 DAYS TO 36 MONTHS INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)
INTERVENTIONAL
Inicio: 26 de abr de 2022
ID: NCT04816721
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK Inhibitor Therapy and Who Require Red Blood Cell Transfusions
INTERVENTIONAL
Inicio: 25 de feb de 2021
ID: NCT04717414
Completado
Fase 3
ClinicalTrials.gov
A 52-week Treatment, Multi-center, Randomized, Double-blind, Double Dummy, Parallel-group, Active Controlled Study to Compare the Effect of QVA149 (Indacaterol Maleate / Glycopyrronium Bromide) With Salmeterol/Fluticasone on the Rate of Exacerbations in Subjects With Moderate to Very Severe COPD. (FLAME).
INTERVENTIONAL
Inicio: 1 de jul de 2013
ID: NCT01782326
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Prospective, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Sequential Intravenous/Oral Moxifloxacin in Comparison to Intravenous Levofloxacin Plus Intravenous Ceftriaxone Followed by Oral Levofloxacin, in the Treatment of Patients With Severe Community-acquired Pneumonia
INTERVENTIONAL
Inicio: 1 de ene de 2004
ID: NCT00431678
Completado
Fase 4
ClinicalTrials.gov
Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation.
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT01803438
Activo, no recluta
ClinicalTrials.gov
A Non-Interventional, Multicenter, Multiple Cohort Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
OBSERVATIONAL
Inicio: 7 de feb de 2019
ID: NCT03782207
Activo, no recluta
ClinicalTrials.gov
Surveillance AFter Extremity Tumor surgerY (SAFETY) International Randomized Controlled Trial
INTERVENTIONAL
Inicio: 19 de nov de 2019
ID: NCT03944798
Reclutando
ClinicalTrials.gov
Characteristics of Patients With Autoimmune Interstitial Lund Disease From Argentina
OBSERVATIONAL
Inicio: 10 de abr de 2022
ID: NCT05365009
Terminado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Group, Adaptive Phase 3 Study With Open-label Extension to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
INTERVENTIONAL
Inicio: 7 de jul de 2020
ID: NCT04271475
Completado
Fase 3
ClinicalTrials.gov
Phase III Randomized Trial of BIBW 2992 Plus Weekly Paclitaxel Versus Investigator's Choice of Chemotherapy Following BIBW 2992 Monotherapy in Non-small Cell Lung Cancer Patients Failing Previous Erlotinib or Gefitinib Treatment (LUX Lung 5)
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01085136
Desconocido
ClinicalTrials.gov
HypErsensitiVity PneumonITis: DiseAse Progression Characterization. An International Multicentric Prospective Observational Study
OBSERVATIONAL
Inicio: 20 de jun de 2022
ID: NCT04961944
Retirado
Fase 2
ClinicalTrials.gov
A Phase 1/2, Randomized Study Evaluating Multiple Nivolumab Combination Therapies in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy and Anti-PD-1 (L)1 Immunotherapy
INTERVENTIONAL
Inicio: 15 de abr de 2021
ID: NCT04151563
Completado
Fase 4
ClinicalTrials.gov
Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma
INTERVENTIONAL
Inicio: 10 de jul de 2017
ID: NCT02889809
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Trial Comparing the Efficacy and Safety of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily With Tiotropium 18 mcg Once Daily Over 24 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 23 de ene de 2013
ID: NCT01777334
Aún no recluta
Fase 3
ClinicalTrials.gov
An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
INTERVENTIONAL
Inicio: 16 de dic de 2026
ID: NCT07441408
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Open-label Trial to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Lenvatinib (E7080/MK-7902) Versus Docetaxel in Previously Treated Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (LEAP-008)
INTERVENTIONAL
Inicio: 26 de jun de 2019
ID: NCT03976375
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Double-dummy, Parallel Group, Multicenter Study of Once Daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, Twice Daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Twice Daily Fluticasone Propionate 250 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents Already Adequately Controlled on Twice-daily Inhaled Corticosteroid and Long-acting beta2 Agonist
INTERVENTIONAL
Inicio: 1 de mar de 2015
ID: NCT02301975
Completado
Fase 2
ClinicalTrials.gov
A Pilot Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Subjects Infected With Respiratory Syncytial Virus
INTERVENTIONAL
Inicio: 6 de feb de 2018
ID: NCT03379675
Anterior
1
...
6
7
8
...
434
Siguiente
Filtros